According to Fortune Business Insights, the global viral vaccines market was valued at USD 94.95 billion in 2022 and is projected to grow from USD 52.42 billion in 2023 to USD 70.99 billion by 2030, exhibiting a CAGR of 4.4% during the forecast period (2023–2030). In 2022, Asia Pacific dominated the viral vaccines market with a market share of 29.08%.